Home/Filings/4/0000899243-21-015634
4//SEC Filing

RiverVest Venture Fund III, L.P. 4

Accession 0000899243-21-015634

CIK 0001637715other

Filed

Apr 12, 8:00 PM ET

Accepted

Apr 13, 5:54 PM ET

Size

19.2 KB

Accession

0000899243-21-015634

Insider Transaction Report

Form 4
Period: 2021-04-09
Transactions
  • Conversion

    Common Stock

    2021-04-09+829,1132,209,220 total(indirect: See footnote)
  • Conversion

    Series A Preferred Stock

    2021-04-094,925,7110 total(indirect: See footnote)
    Common Stock (1,100,765 underlying)
  • Conversion

    Series B Preferred Stock

    2021-04-093,710,1160 total(indirect: See footnote)
    Common Stock (829,113 underlying)
  • Conversion

    Common Stock

    2021-04-09+1,100,7651,380,107 total(indirect: See footnote)
  • Purchase

    Common Stock

    2021-04-09$15.00/sh+200,000$3,000,0002,409,220 total(indirect: See footnote)
Transactions
  • Conversion

    Common Stock

    2021-04-09+829,1132,209,220 total(indirect: See footnote)
  • Conversion

    Series A Preferred Stock

    2021-04-094,925,7110 total(indirect: See footnote)
    Common Stock (1,100,765 underlying)
  • Conversion

    Common Stock

    2021-04-09+1,100,7651,380,107 total(indirect: See footnote)
  • Purchase

    Common Stock

    2021-04-09$15.00/sh+200,000$3,000,0002,409,220 total(indirect: See footnote)
  • Conversion

    Series B Preferred Stock

    2021-04-093,710,1160 total(indirect: See footnote)
    Common Stock (829,113 underlying)
Transactions
  • Purchase

    Common Stock

    2021-04-09$15.00/sh+200,000$3,000,0002,409,220 total(indirect: See footnote)
  • Conversion

    Series B Preferred Stock

    2021-04-093,710,1160 total(indirect: See footnote)
    Common Stock (829,113 underlying)
  • Conversion

    Series A Preferred Stock

    2021-04-094,925,7110 total(indirect: See footnote)
    Common Stock (1,100,765 underlying)
  • Conversion

    Common Stock

    2021-04-09+1,100,7651,380,107 total(indirect: See footnote)
  • Conversion

    Common Stock

    2021-04-09+829,1132,209,220 total(indirect: See footnote)
Footnotes (8)
  • [F1]Each share of Series A Preferred Stock and Series B Preferred Stock automatically converted into 1 share of the Issuer's common stock for each 4.4748 shares of Preferred Stock upon the closing of the Issuer's initial public offering on April 9, 2021. The shares have no expiration date.
  • [F2]Consists of shares held of record by (i) RiverVest Venture Fund III, L.P. ("RiverVest III"), (ii) RiverVest Venture Fund III (Ohio), L.P. ("RiverVest (Ohio) III"), and (iii) RiverVest Venture Fund IV, L.P ("RiverVest IV").
  • [F3]The shares held by RiverVest III are indirectly held by RiverVest Venture Partners III, L.P. ("RiverVest Partners III"), which is the general partner of RiverVest III. The shares held by RiverVest (Ohio) III are indirectly held by RiverVest Venture Partners III (Ohio), LLC ("RiverVest Partners (Ohio) III"), which is the general partner of RiverVest (Ohio) III. RiverVest Partners III is the sole member of RiverVest Partners (Ohio) III. RiverVest Venture Partners III, LLC is the general partner of RiverVest Partners III.
  • [F4]The individual managers of RiverVest Ventures Partners III, LLC are Thomas C. Melzer, Jay Schmelter and John P. McKearn, Ph.D. RiverVest Partners III, RiverVest Partners (Ohio) III, RiverVest Venture Partners III, LLC and each of the individual managers share voting and dispositive power with regard to the Issuer's securities directly held by RiverVest Venture Fund III, L.P. and RiverVest Venture Fund III (Ohio), L.P.
  • [F5]Consists of shares held of record by RiverVest IV.
  • [F6]The shares held by RiverVest IV are indirectly held by RiverVest Venture Partners IV, L.P., its general partner ("RiverVest Partners IV"). RiverVest Venture Partners IV, LLC is the general partner of RiverVest Partners IV. The individual managers of RiverVest Ventures Partners IV, LLC are Jay Schmelter, John P. McKearn, Ph.D. and Niall O'Donnell, a member of the Issuer's board of directors. RiverVest Partners IV, RiverVest Venture Partners IV, LLC and each of the individual managers share voting and dispositive power with regard to the Company's securities directly held by RiverVest IV.
  • [F7]RiverVest IV purchased the shares in the Issuer's initial public offering.
  • [F8]The 2,409,220 shares consists of (i) 328,094 shares held of record by RiverVest III, (ii) 17,413 shares held of record by RiverVest (Ohio) III, and (iii) 2,063,713 shares held of record by RiverVest IV.

Issuer

Reneo Pharmaceuticals, Inc.

CIK 0001637715

Entity typeother
IncorporatedDE

Related Parties

1
  • filerCIK 0001601559

Filing Metadata

Form type
4
Filed
Apr 12, 8:00 PM ET
Accepted
Apr 13, 5:54 PM ET
Size
19.2 KB